Gastrointestinal cancers (including colorectal cancer, gastric cancer, esophageal cancer, pancreatic cancer, biliary and liver cancers, anal cancer, neuroendocrine tumors, and gastrointestinal stromal tumors), clinical trials of novel therapies and combinations including phase I-III clinical trials, translational research into novel biomarkers
BS: Johns Hopkins University, 2005; MD: Duke University, 2009; Resident: Brigham and Women’s Hospital, 2009-2012; Fellowship: University of Texas M.D. Anderson Cancer Center, 2012-2015; Assistant Professor of Medicine: University of North Carolina, 2015-present.
It is my privilege to care for patients with gastrointestinal cancers as a medical oncologist. I am passionate about developing novel therapies by performing clinical research investigating these new treatments and performing studies to better identify potential biomarkers describing susceptibility or resistance to these therapies. In so doing, I aim to better understand the unique drivers underlying how different patients may respond differently to varying treatments, and thus advance our ability to treat these diseases.